div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documentnumir-de-limfocite-x-1091-sau-x-1091-tn-cursul-tratamentului-cu-tecfideta-fnhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: numir de limfocite x 1091 sau x 1091 tn cursul tratamentului cu Tecfideta fn cadrul studillor clinice placebo controlate pentru SM valoarea medie a numIrulu5- de limfocite a acnzut loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentecomreader033viewer20220417195e4d3b5ec2a03f16585a6e74html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documentnumir-de-limfocite-x-1091-sau-x-1091-tn-cursul-tratamentului-cu-tecfideta-fnhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: numir de limfocite x 1091 sau x 1091 tn cursul tratamentului cu Tecfideta fn cadrul studillor clinice placebo controlate pentru SM valoarea medie a numIrulu5- de limfocite a acnzut loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentecomreader033viewer20220417195e4d3b5ec2a03f16585a6e74html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documentnumir-de-limfocite-x-1091-sau-x-1091-tn-cursul-tratamentului-cu-tecfideta-fnhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: numir de limfocite x 1091 sau x 1091 tn cursul tratamentului cu Tecfideta fn cadrul studillor clinice placebo controlate pentru SM valoarea medie a numIrulu5- de limfocite a acnzut loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...